Evommune, Inc. carries a market capitalization of 173.09M, placing it among publicly traded companies globally.
| Market Cap | 173.09M |
| Enterprise Value | N/A |
Evommune, Inc.'s stock has declined approximately -39.59466% over the past 52 weeks. The 50-day moving average sits at 19.06, while the 200-day moving average is 21.19.
| Beta (5Y) | N/A |
| 52-Week Price Change | -39.59466% |
| 50-Day Moving Average | 19.06 |
| 200-Day Moving Average | 21.19 |
| Average Volume (20 Days) | N/A |